15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 8.5% per year over the past 5 years.
Net income has grown faster than revenue (9.5% vs 8.5% per year).
Operating margin has been roughly flat, at 11.5% in the latest year.
Free cash flow has declined 12.2% per year over the past 5 years.
Financial health
Total debt ($4.8B) exceeds cash ($138M); net debt is $4.7B.
Total debt has grown slower than revenue (4.5% vs 8.5% per year).
Operating income covered interest expense 13× in the latest year, down from 13× 5 years ago.
Total debt is 1.8× EBITDA.
Shareholder returns
Dividends have been paid for 9 consecutive years, consuming 3.4% of earnings and 6.0% of free cash flow.
The dividend has grown 24.2% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$17.4B
$1.5B
0.0%
11.5%
20.5%
9.6%
$849M
$4.8B
$138M
2024
$15.8B
$1.1B
0.0%
10.6%
17.1%
7.9%
$1.1B
$4.5B
$126M
2023
$14.3B
$718M
0.0%
8.2%
11.7%
5.1%
$525M
$4.9B
$119M
2022
$13.4B
$676M
0.0%
7.5%
11.4%
5.0%
$262M
$4.8B
$103M
2021
$12.6B
$992M
0.0%
10.8%
16.3%
7.6%
$28M
$4.2B
$115M
2020
$11.6B
$944M
0.0%
11.8%
14.9%
7.0%
$1.6B
$3.9B
$1.2B
2019
$11.4B
$815M
0.0%
10.7%
14.8%
7.0%
$804M
$4.0B
$61M
2018
$10.8B
$780M
0.0%
10.9%
14.5%
6.9%
$610M
$4.0B
$105M
2017
$10.4B
$752M
0.0%
12.3%
15.1%
7.0%
$690M
$4.0B
$74M
2016
$9.8B
$702M
0.0%
13.1%
15.5%
6.8%
$814M
$4.1B
$34M
2015
—
$681M
—
—
16.0%
7.1%
$689M
$3.4B
$61M
2014
—
$545M
—
—
14.6%
6.1%
$645M
$3.3B
$32M
2013
—
$511M
—
—
15.7%
6.1%
$526M
$3.3B
$17M
2012
—
$443M
—
—
16.3%
5.4%
$436M
$3.7B
$23M
2011
—
$398M
—
—
17.3%
5.2%
$425M
$3.7B
$41M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$4.6B
$358M
0.0%
11.1%
4.8%
2.2%
$216M
$4.9B
$139M
Mar '26
$4.5B
$349M
0.0%
11.2%
4.7%
2.2%
$184M
$4.7B
$119M
Dec '25
$4.5B
$446M
0.0%
11.5%
6.1%
2.9%
$293M
$4.8B
$138M
Sep '25
$4.5B
$373M
0.0%
11.6%
5.2%
2.4%
$152M
$4.7B
$113M
Jun '25
$4.3B
$353M
0.0%
11.7%
5.0%
2.4%
$283M
$4.6B
$138M
Mar '25
$4.1B
$317M
0.0%
11.1%
4.7%
2.1%
$121M
$4.6B
$127M
Dec '24
$4.1B
$332M
0.0%
11.5%
5.0%
2.3%
$412M
$4.5B
$126M
Sep '24
$4.0B
$259M
0.0%
9.7%
3.9%
1.8%
$85M
$4.7B
$106M
Jun '24
$3.9B
$289M
0.0%
11.2%
4.5%
2.1%
$438M
$4.5B
$129M
Mar '24
$3.8B
$262M
0.0%
10.1%
4.2%
1.9%
$188M
$4.9B
$112M
Dec '23
$3.7B
$216M
0.0%
8.9%
3.5%
1.5%
$246M
$4.9B
$119M
Sep '23
$3.6B
$167M
0.0%
8.0%
2.8%
1.2%
-$38M
$4.9B
$81M
Jun '23
$3.5B
$171M
0.0%
7.9%
2.8%
1.2%
$195M
$4.7B
$79M
Mar '23
$3.5B
$163M
0.0%
8.0%
2.7%
1.2%
$122M
$4.8B
$110M
Dec '22
$3.4B
$175M
0.0%
7.6%
3.0%
1.3%
$133M
$4.8B
$103M
Sep '22
$3.3B
$183M
0.0%
8.3%
3.1%
1.4%
$59M
$4.7B
$75M
Jun '22
$3.3B
$164M
0.0%
7.0%
2.8%
1.2%
-$175M
$4.7B
$133M
Mar '22
$3.3B
$154M
0.0%
7.1%
2.6%
1.2%
$245M
$4.3B
$106M
Dec '21
$3.3B
$239M
0.0%
9.6%
3.9%
1.8%
$132M
$4.2B
$115M
Sep '21
$3.2B
$218M
0.0%
10.0%
3.5%
1.7%
$258M
$3.8B
$190M
Valuation over time
How the market has priced UHS against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 11.1× (Mar '23) to 7.2× (Nov '26).
The price-to-sales ratio has risen from 0.6× (Mar '23) to 0.6× (Nov '26).
The dividend yield has fallen from 0.8% (Mar '23) to 0.5% (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is UHS growing its revenue and profit?
Over the past 5 years, Universal Health Services's revenue has grown 8.5% per year, and net income grown 9.5% per year. These are computed facts, not advice.
How much debt does UHS have?
As of FY2025, Universal Health Services reported $4.8B of total debt against $138M of cash; operating income covered interest expense 13×.
What is UHS's profit margin?
In FY2025, gross margin was —, operating margin 11.5%, and net margin 8.6%.
What is UHS's P/E ratio?
Universal Health Services's P/E (TTM) is 6.98 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the UHS stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 7.2× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.